GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
  • Research
    • Cross-cutting issues
      • Antimicrobial Resistance and Drug Discovery
      • Host–Pathogen Interactions
      • Genomic Surveillance and Population Mobility
      • Implementation and Translational Research
      • Information for Health Development
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • PRIME – Pathogen resistance, infection and molecular epidemiology
      • VBD – Vector borne diseases
      • CTM – Clinical tropical medicine
    • Research in numbers
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
    • BIOHUB & Available Software
    • BIOTROP Biobank
    • VIASEF & Insectaries
  • Networks & Partnerships
Home / Articles / GHTM researcher Ana Armada appointed to the Management Committee of COST Action – ONE-LEP

GHTM researcher Ana Armada appointed to the Management Committee of COST Action – ONE-LEP

August 26, 2026

Ana Armada, researcher at the PRIME-GHTM Research Group, has been appointed as Portugal’s Management Committee Member for COST Action CA25142 – ONE-LEP: One Health European Network for Leptospirosis and Rodent-Borne Threats.

Following her nomination, Ana Armada has formally accepted the position and will represent Portugal as a full member of the Management Committee of this new COST Action.

Advancing a One Health approach to leptospirosis

Leptospirosis represents an important public health, animal health and ecological challenge in Europe. Its complex transmission dynamics, alongside increasing human cases, expanding rodent populations, challenges in rodent control, gaps in surveillance and diagnosis, and limited prevention options, highlight the need for a coordinated and integrated approach.

ONE-LEP aims to establish a network of excellence that will integrate, harmonise and disseminate existing knowledge while supporting the development of innovative services and tools. Adopting a One Health framework, the Action brings together expertise in human, veterinary, environmental and wildlife health to strengthen scientific capacity, partnerships and infrastructure for addressing leptospirosis and the wider rodent–pathogen interface.

The network is structured around five Working Groups, which will coordinate existing and emerging activities related to leptospirosis across Europe. Ultimately, ONE-LEP seeks to contribute to stronger healthcare systems, support evidence-based policymaking and improve health outcomes for both humans and animals affected by leptospirosis.

Building an international network

ONE-LEP brings together professionals from academia, government and non-governmental organisations across a broad international network. Participants represent 32 COST Full Member countries, including Portugal, alongside the Cooperating Member Israel and Partner Member South Africa. The Action also promotes collaboration with Egypt as a Near Neighbour Country and Brazil, Madagascar and the United States as International Partner countries.

The network places particular emphasis on gender balance and the active participation of Young Researchers and Innovators (YRIs), with special attention to researchers from underrepresented groups and Inclusiveness Target Countries.

Ana Armada’s appointment provides an important opportunity for Portugal to contribute to the strategic development of ONE-LEP and to strengthen national participation in this international research network. It also further enhances the visibility and engagement of the PRIME-GHTM Research Group and the GHTM research community in European and international research collaborations.

GHTM | IHMT NOVA congratulates Ana Armada on her appointment and wishes her every success in this new role.

Learn more about COST Action CA25142 – ONE-LEP here.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Funding

UID/04413/2025 - DOI: 10.54499/UID/04413/2025

UID/PRR/04413/2025 - DOI: 10.54499/UID/PRR/04413/2025

UID/PRR2/04413/2025 - DOI: 10.54499/UID/PRR2/04413/2025

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.